Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Eye Neoplasms × MAGEA3 protein, human × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 5 Uveal Melanoma 2 Skin Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Eye Neoplasms 1

Interventions

montanide ISA 51 1 binimetinib 1 belinostat 1 Proton Therapy 1 Peptides 1 Melphalan 1 MART-1 Antigen 1 MAGEA3 protein, human 1 Leuprolide 1 Laparotomy 1 Interleukin-2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00254397 2019-10-16

Melanoma Vaccine With Peptides and Leuprolide

M.D. Anderson Cancer Center

Phase 2 Completed

98 enrolled 11 charts

Uveal Melanoma, Eye Neoplasms, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡